The FDA is sending along the information below regarding a new TCA-related research funding opportunity as an example of the research progress underway as well as to promote this specific opportunity for folks/organizations who are interested and eligible.
NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30)
This Funding Opportunity Announcement (FOA) invites revision applications from investigators and institutions/organizations with active National Institutes of Health (NIH)-supported P30 project awards to support an expansion of the scope of approved and funded scientific research programs involving smoking and tobacco-related products and/or their constituents. Investigators and institutions/organizations that are on a funded extension are eligible to apply for a revision. Revision applications for projects that have not originally focused on tobacco use are welcome provided that the applicant team has the requisite scientific expertise and the proposed revision addresses the research priorities related to Food and Drug Administration (FDA) regulatory authority that are identified in the FOA.
The NIH and the FDA have formed an interagency partnership to foster research relevant to tobacco regulations. The awards under this FOA will be administered by NIH using designated funds from the FDA Center for Tobacco Products (CTP) for tobacco regulatory science mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. Projects resulting from this FOA are expected to serve the FDA by generating relevant findings and data needed to inform the regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.